Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer
Author:
Affiliation:
1. Department of Urology, University Hospital, Tübingen, Germany
2. Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada
3. Inselspital Bern, Bern, Switzerland
Publisher
IOS Press
Subject
Urology,Oncology
Reference49 articles.
1. Liquid biopsy: Ready to guide therapy in advanced prostate cancer?;Hegemann;BJU International,2016
2. Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy;Alix-Panabieres;Cancer Discovery,2016
3. Free DNA in the serum of cancer patients and the effect of therapy;Leon;Cancer Research,1977
4. Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease;Olsson;EMBO Molecular Medicine,2015
5. Goodall J , Mateo J , Yuan W , Mossop H , Porta N , Miranda S , Perez-Lopez R , Dolling D , Robinson DR , Sandhu S , Fowler G , Ebbs B , Flohr P , Seed G , Rodrigues DN , Boysen G , Bertan C , Atkin M , Clarke M , Crespo M , Figueiredo I , Riisnaes R , Sumanasuriya S , Rescigno P , Zafeiriou Z , Sharp A , Tunariu N , Bianchini D , Gillman A , Lord CJ , Hall E , Chinnaiyan AM , Carreira S , de Bono JS , investigators T-A. Circulating Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition. Cancer Discovery 2017.
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Applications of Biosensors in Bladder Cancer;Critical Reviews in Analytical Chemistry;2024-07-08
2. Hot technology and technical evolution of polypeptide nanotechnology in medical application field based on patent data analysis;Journal of Nanoparticle Research;2024-06-27
3. Change in the neutrophil‐lymphocyte ratio may predict early recurrence in operated bladder cancer;Asia-Pacific Journal of Clinical Oncology;2024-04-04
4. Fibroblast growth factor receptor 1 inhibition suppresses pancreatic cancer chemoresistance and chemotherapy-driven aggressiveness;Drug Resistance Updates;2024-03
5. Precision medicine for urothelial carcinoma: An international perspective;Urologic Oncology: Seminars and Original Investigations;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3